ORCHID PHARMA LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,003 INR | -0.33% |
|
-2.36% | +40.73% |
| 24/05 | Transcript : Orchid Pharma Limited, Q4 2024 Earnings Call, May 24, 2024 | |
| 23/05 | Orchid Pharma Limited Appoints Shubha Singh as Additional Director | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 61Cr | - | - | - | - | - | |
| 74TCr | ||||||
| 60TCr | ||||||
| 35TCr | ||||||
| 32TCr | ||||||
| 28TCr |
